Fesoterodine Fumarate 62332-0175-10
- Manufacturer
- Alembic Pharmaceuticals Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- January 6, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA204973
Need to source Fesoterodine Fumarate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fesoterodine Fumarate | 4 mg/1 |
Selected Package
62332-0175-10Selected100 TABLET, EXTENDED RELEASE in 1 CARTON (62332-175-10)
Other packages for this product(3)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-175-30)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-175-90)
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-175-91)